Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months Journal Articles

Overview
Research
Identity
Additional Document Info
View All

abstract

This case-control study estimates the effectiveness of maternal postpartum messenger RNA (mRNA) COVID-19 vaccination against Delta and Omicron SARS-CoV-2 infection and hospitalization in infants younger than 6 months.

authors

D'Souza, Rohan
Jorgensen, Sarah CJ
Hernandez, Alejandro
Fell, Deshayne B
Austin, Peter C
D’Souza, Rohan
Guttmann, Astrid
Kwong, Jeffrey C

status

published

publication date

April 1, 2023

has subject area

COVID-19 (MeSH)
COVID-19 Vaccines (MeSH)
Female (MeSH)
Hospitalization (MeSH)
Humans (MeSH)
Infant (MeSH)
RNA, Messenger, Stored (MeSH)
SARS-CoV-2 (MeSH)
Vaccination (MeSH)

published in

JAMA pediatrics Journal